Cystoscopy bundling denials
The single biggest urology coding leak — a diagnostic code billed with a therapeutic one is dropped automatically
No specialty crams more distinct billing challenges into a single practice than urology. In one week you might bill diagnostic and therapeutic cystoscopies, kidney-stone lithotripsy, a prostate biopsy under the brand-new 2026 codes, complex urodynamic testing, and expensive buy-and-bill drugs like Lupron and BCG. Each one has its own bundling edits, modifiers, frequency limits, and documentation rules — and a generalist biller misses them constantly.
Our urology billing services are built for exactly that complexity. We handle the cystoscopy bundling edits that trip up everyone else, the urodynamics component rules, the buy-and-bill drug units, and the surgical global periods — so every procedure is billed correctly and paid in full.
Get a free urology billing audit. We'll review your recent claims and show you, in writing, where revenue is leaking — cystoscopy bundling denials, undercoded urodynamics, uncaptured drug units, expired authorizations — and exactly how much we can help you recover. No cost, no obligation, findings yours to keep.
The single biggest urology coding leak — a diagnostic code billed with a therapeutic one is dropped automatically
Component and frequency rules misapplied, so complex in-office testing is denied or underpaid
Lupron, BCG, and Botox units and wastage under-billed on high-cost drugs
Practices still using the retired prostate biopsy code now deny outright under the 2026 codes
High-value procedures and drug therapies denied for auths that lapsed unappealed
Modifier 25, 59, and right/left errors on kidney and ureter claims, a leading denial cause
Urodynamics, PSA, and imaging billed outside payer limits with no supporting documentation
A general biller can process an office visit. Urology overwhelms them, because it combines more distinct billing systems than almost any other specialty — and each has its own traps.
Diagnostic and therapeutic cystoscopy, kidney-stone surgery, prostate biopsy and treatment, bladder tumor resection, urodynamic testing, and minimally invasive BPH procedures — each with its own code family, bundling rules, and documentation standards. Few specialties span this range in a single clinic.
Urology's most common procedure, cystoscopy, carries a bundling edit that automatically drops the diagnostic code whenever a therapeutic one is billed in the same session. This single edit causes more urology denials than any other coding mistake — and generalist billers walk into it every day.
If you administer Lupron, intravesical BCG, or bladder Botox, you're effectively running a buy-and-bill drug operation on top of your procedures — with J-codes, units, NDCs, and wastage rules that most billers mishandle, leaving significant drug revenue uncollected.
The prostate biopsy codes were completely restructured for 2026, catheter supply codes were replaced, and payer bundling and frequency policies shift constantly. Anything that slips through comes back as a denial or an underpayment.
This one deserves its own attention, because it quietly costs urology practices more than any other coding mistake.
The diagnostic cystoscopy code is designated a "separate procedure," which means the moment any intervention happens in the same session — a biopsy, a fulguration, a tumor resection, a stent placement, a Botox injection, a stone removal — the therapeutic code takes over, and the diagnostic code cannot ride on the same claim.
Payers drop it automatically, without even asking for documentation. Bill both together and you don't just lose the diagnostic code; you often trigger a denial that has to be reworked.
We prevent it at the source. Our coders read the operative note to determine whether the encounter stayed purely diagnostic or crossed into a therapeutic intervention, select the single correct code, and apply the distinct-service modifier only when a genuinely separate procedure at a separate site supports it — with the documentation to back an appeal.
Your cystoscopy claims stop bouncing, and the revenue stops leaking.
We don't offer a generic package with a urology label. Every service below is built around how urology practices actually earn — and lose — revenue.
We code every diagnostic and therapeutic cystoscopy correctly, apply the bundling edits and distinct-service modifiers when a scope is paired with stone removal, biopsy, or stent placement, and make sure separately payable services are paid distinctly instead of collapsed into a single underpayment. This is the highest-volume, highest-leak area in urology, and it's where we start.
For TURP, TURBT, nephrectomy, and other surgical procedures, we handle the global periods so post-operative visits aren't billed by mistake, capture the separately payable services with the correct global modifiers, and code multi-procedure sessions so nothing bundles away that shouldn't.
Urodynamic studies are a common revenue leak because their component and global billing rules are so often misapplied. We code each study correctly, meet the frequency limits and medical-necessity criteria payers demand, and document the "why" behind every test — so this valuable in-office service actually gets paid.
From shockwave lithotripsy to ureteroscopy with stone removal and stent placement, we code stone procedures accurately, apply the correct laterality modifiers for kidney and ureter, and link the specific stone diagnosis that establishes medical necessity.
We've fully implemented the 2026 prostate biopsy code overhaul — the new code series that reflects imaging guidance, MRI-fusion technique, and targeted lesions — so practices still on the retired code stop denying. We also code BPH procedures, minimally invasive treatments like UroLift and Rezum, and prostate cancer surgery accurately.
For Lupron and other androgen-deprivation therapies, intravesical BCG, and bladder Botox, we keep the J-codes, units, NDCs, and documented wastage accurate and confirm authorization is active — so your high-cost drug claims are paid in full instead of leaking revenue on units and modifiers.
Advanced imaging, androgen-deprivation therapy, and many procedures require pre-authorization, and a missing or expired approval denies a high-value claim outright. Our team identifies what needs authorization, gathers the documentation, and keeps every approval active through the course of care.
Vague, unspecified diagnosis codes are a primary cause of urology denials. We move each encounter from symptom codes to the definitive diagnosis, link every procedure and test to the specific diagnosis that supports it, and include the laterality and secondary conditions that strengthen medical necessity.
We bill catheters and urological supplies under the current 2026 HCPCS codes with the documentation of supply type, quantity, and frequency that payers now require — so supply claims don't deny or trigger post-payment audits.
Our denial management team works every denied urology claim to its root cause — bundling, modifiers, laterality, frequency, medical necessity — fixes the process behind it, and appeals what's owed, so the same denial stops repeating.
We handle credentialing and enrollment for your urologists and advanced-practice providers across every payer, starting at hire, so no provider is performing procedures they can't yet bill for. Reliable urology credentialing keeps revenue flowing from day one, and we help close gaps at re-credentialing too.
Clear monthly reporting on clean-claim rate, denial rate by category, cystoscopy and urodynamics capture, drug-revenue accuracy, days in A/R, and revenue by procedure and provider — so you always know exactly how your practice is performing.
Correct diagnostic-versus-therapeutic coding and clean bundling, so your highest-volume procedure stops leaking revenue.
Lupron, BCG, and Botox billed with accurate units, NDCs, and wastage, so expensive drug claims pay in full.
Correct modifiers, laterality, frequency documentation, and current codes keep your first-pass acceptance high and your rework low.
A dedicated team keeps procedure and drug approvals active, so high-value claims don't die at billing.
We take coding, claims, prior auth, appeals, and patient billing off your staff, so they can focus on patients instead of chasing denials.
Whether you're a solo urologist who needs the billing off your desk or a large group running procedures, testing, and drug therapies across multiple sites, we build around how your practice actually operates — and scale with you.
Cystoscopy bundling, urodynamics components, buy-and-bill drugs, the 2026 prostate biopsy codes, surgical global periods — this is what we do every day, and it shows up directly in your collections.
Commercial payer bundling and frequency policies vary, and that variance is where urology practices lose money. We maintain payer-specific rules and code every claim the way that payer actually pays.
The free audit shows you, in writing, the revenue we can recover — so you decide with real numbers, not promises.
Transparent pricing, honest reporting, and no long-term contract locking you in. If we're not improving your collections within 90 days, you're free to leave.
Our incentives are tied to your revenue, so we're driven to capture every procedure and every drug unit you've earned.
A connected claim-control track shows exactly what happens, how long it takes, and what your practice receives at every stage.
Tell us about your practice — your procedure mix, whether you run urodynamics or buy-and-bill drugs, your payer mix. A five-minute form, confirmed within one business day.
Within about a week, you'll get a clear picture of where you're losing revenue — cystoscopy bundling, undercoded urodynamics, uncaptured drug units, expired authorizations — and how much we can recover. Yours to keep.
We work inside your existing system, so nothing changes about your clinic or your procedure schedule. Most practices are fully live in two to three weeks, with no gap in claims.
Every month, you see higher collections, fewer denials, captured drug revenue, and a lighter load on your team.
Because the diagnostic cystoscopy code is a "separate procedure" that bundles into any therapeutic cystoscopy performed in the same session. The moment a biopsy, fulguration, tumor resection, stent, Botox injection, or stone removal happens, the therapeutic code takes over and the diagnostic code cannot be billed on the same claim — payers drop it automatically. This single bundling edit causes more urology denials than any other coding mistake. We prevent it by coding from the operative note and using distinct-service modifiers only when a genuinely separate procedure supports it.
Urodynamic studies have specific component and global billing rules, frequency limits, and medical-necessity requirements that are frequently misapplied, making them a common revenue leak. Each study must be coded accurately, documented with a clear clinical reason, and kept within the payer's frequency limits. We handle all three so this valuable in-office testing gets reimbursed instead of denied.
The older single prostate biopsy code was deleted and replaced with a new, more specific code series that reflects imaging guidance, MRI-fusion technique, and targeted, lesion-based biopsies. Any practice still billing the retired code now gets automatic denials. We've fully implemented the new codes so your prostate biopsy claims are current and paid.
Androgen-deprivation therapies like Lupron, intravesical BCG for bladder cancer, and bladder Botox are billed with specific J-codes, unit calculations, NDCs, and wastage rules — and they require prior authorization. A missing NDC, wrong unit count, or gap in wastage documentation leaves significant drug revenue uncollected. We keep all of it accurate and confirm authorization is active, so these high-cost claims pay in full.
The leading causes are lack of documented medical necessity, incorrect or missing modifiers (especially 25 and 59), improper unbundling, missing laterality on kidney and ureter procedures, and frequency-limit issues on testing. Most are preventable with urology-specific coding and complete documentation, which is exactly what our denial management focuses on.
No. We work inside your existing EHR and practice-management system, so nothing changes about your clinical day or your procedure schedule. Most practices transition in two to three weeks with no interruption to claims, and start seeing results within the first billing cycle.
Our pricing is transparent and performance-based — we do well when you get paid. The free audit shows you what we can recover, so you can weigh the cost against the revenue before you commit. For most practices, the additional revenue we capture more than covers the service.
Your urologists do the demanding work — the scopes, the stone and prostate procedures, the cancer care that changes lives. You shouldn't lose a slice of that hard-earned revenue to a cystoscopy bundling edit, an undercoded urodynamic study, or a drug unit your biller didn't capture. Our urology billing services make sure every procedure, every test, and every drug is billed correctly, paid fully, and protected from the denials that cost urology practices the most.
Start with the free audit. See the number. Then decide.Share a few details about your practice. The written findings and recovery estimate are yours to keep.